Key statistics
As of last trade MacroGenics Inc (M55:STU) traded at 1.66, -29.40% below its 52-week high of 2.35, set on Feb 27, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.65 |
|---|---|
| High | 1.69 |
| Low | 1.62 |
| Bid | 1.67 |
| Offer | 1.69 |
| Previous close | 1.67 |
| Average volume | 10.10k |
|---|---|
| Shares outstanding | 63.26m |
| Free float | 61.32m |
| P/E (TTM) | -- |
| Market cap | 125.88m USD |
| EPS (TTM) | -1.21 USD |
Data delayed at least 15 minutes, as of Feb 27 2026.
More ▼
Announcements
- MacroGenics to Participate in Upcoming Investor Conferences
- MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
- MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
- MacroGenics to Participate in the Stifel 2025 Healthcare Conference
- MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
- MacroGenics Appoints Eric Risser as President and Chief Executive Officer
- MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
- MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
- MacroGenics Announces Date of First Quarter 2025 Financial Results
- MacroGenics to Participate in Upcoming Investor Conference
More ▼
